Our May list includes an app for titration of basal insulin, GI effects of GLP-1 agonists, and lifestyle intervention studies.
We present a selection of interesting news and research for the month of May focusing on type 2 diabetes. See the slide legends for links to the article summaries.
Serum Lipidomics Reveals Early Differential Effects of Gastric Bypass Compared With Banding on Phospholipids and Sphingolipids Independent of Differences in Weight Loss. Abstract link. **** Mental Illness in Bariatric Surgery: A Cohort Study From the PORTAL Network. Abstract link.
Early Glycemic Control and Magnitude of HbA1c Reduction Predict Cardiovascular Events and Mortality: Population-Based Cohort Study of 24,752 Metformin Initiators. Abstract link. **** Genetic Variation at the Sulfonylurea Receptor, Type 2 Diabetes, and Coronary Heart Disease. Abstract link.
Global Economic Burden of Diabetes and Its Implications. Abstract link. **** Statin Therapy Reduces Future Risk of Lower Limb Amputation in Patient With Diabetes and Peripheral Artery Disease. Abstract link.
Diabetes Among Non-Obese Filipino Americans: Findings From a Large Population-Based Study. Abstract link. **** Endocrine Comorbidities in Patients With Psoriatic Arthritis: A Population-Based Case-Controlled Study. Abstract link.
Amalgam Rx Unveils iSage Rx, the First FDA-Cleared Application for Titration of All Brands of Basal Insulin. Press release. **** FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy, the Leading Cause of Blindness Among Working Age Adults in the United States. Press release.
A Nurse-Led Education and Cognitive Behaviour Therapy-Based Intervention Among Adults With Uncontrolled Type 2 Diabetes: A Randomised Controlled Trial. Abstract link. **** Long-term Cost Reduction of Routine Medications Following a Residential Programme Combining Physical Activity and Nutrition in the Treatment of Type 2 Diabetes: A Prospective Cohort Study. Abstract link.
Upper and/or Lower Gastrointestinal Adverse Events With Glucagon-Like Peptide-1 Receptor Agonists: Incidence and Consequences. Abstract link. **** Rates of Hypoglycaemia Are Lower in Patients Treated With Insulin Degludec/Liraglutide (IDegLira) Than With IDeg or Insulin Glargine Regardless of the Hypoglycaemia Definition Used. Abstract link.
Brain Changes in Overweight/Obese and Normal-Weight Adults With Type 2 Diabetes Mellitus. Abstract link. **** Effect of Alternate-Day Fasting on Weight Loss, Weight Maintenance, and Cardioprotection Among Metabolically Healthy Obese Adults: A Randomized Clinical Trial. Abstract link.
Modeling the Economic and Health Impact of Increasing Children’s Physical Activity in the United States. Abstract link. **** Genome-Wide Physical Activity Interactions in AdiposityâA Meta-analysis of 200,452 Adults. Abstract link.